Article Information
History
- August 11, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sami Harba,b,
- Julie Cumina,
- Danielle B. Ricea,c,
- Sandra Peláeza,d,
- Marie Hudsona,e,
- Susan J. Bartlette,
- Alexandra Rorenf,
- Daniel E. Furstg,
- Tracy M. Frechh,
- Christelle Nguyeni,
- Warren R. Nielsonj,
- Brett D. Thombsa,b,c,d,e,k,
- Ian Shriera,*,
- SPIN-PACE Patient Advisory Team
- aLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada
- bDepartment of Psychiatry, McGill University, Montreal, Quebec, Canada
- cDepartment of Psychology, McGill University, Montreal, Quebec, Canada
- dDepartment of Educational and Counselling Psychology, McGill University, Montreal, Quebec, Canada
- eDepartment of Medicine, McGill University, Montreal, Quebec, Canada
- fAP-HP Cochin Hospital, Université Paris Descartes Sorbonne Paris Cité, and INSERM U1153, Paris, France
- gDivision of Rheumatology, Geffen School of Medicine, University of California, Los Angeles
- hDepartment of Internal Medicine, University of Utah, Salt Lake City, Utah, USA
- iUniversité de Paris, Faculté de Santé, UFR Médecine Paris Descartes; Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Service de Rééducation et de Réadaptation de l’Appareil Locomoteur et des Pathologies du Rachis; and INSERM UMR 1124, Paris, France
- jSt. Joseph’s Health Care and the Lawson Health Research Institute, London, Ontario, Canada
- kDepartment of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada
- lScleroderma Patient-centered Intervention Network – Physical ACtivity Enhancement (SPIN-PACE) Patient Advisory Team members: Lindsay Cronin, Southwestern Pennsylvania Scleroderma Support Group, Pittsburgh, Pennsylvania, USA; Catherine Fortuné, Ottawa Scleroderma Support Group, Ottawa, Ontario, Canada; Amy Gietzen, Scleroderma Foundation, Danvers, Massachusetts, USA; Geneviève Guillot, Sclérodermie Québec, Longueuil, Quebec, Canada; Shirley Haslam, Scleroderma Society of Ontario, Hamilton, Ontario, Canada; Karen Nielsen, Scleroderma Society of Ontario, Hamilton, Ontario, Canada; Michelle Richard, Scleroderma Society of Nova Scotia, Halifax, Nova Scotia, Canada; Ken Rozee, Scleroderma Society of Nova Scotia, Halifax, Nova Scotia, Canada; Joep Welling, Federation of European Scleroderma Associations, Brussels, Belgium
- ↵*Corresponding Author: Ian Shrier, Jewish General Hospital; 3755 Côte-Sainte-Catherine Road; Montreal, Quebec, Canada; H3T 1E2; Telephone: (514) 340-8222 ext. 27563; Email: ian.shrier{at}mcgill.ca.